Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Leukemia 186Leukemia, Myeloid, Acute 103Myelodysplastic Syndromes 78Lymphoma 73Burkitt Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 49Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Non-Hodgkin 44Hodgkin Disease 41Lymphoma, Large B-Cell, Diffuse 40Leukemia, Myeloid, Chronic-Phase 39Graft vs Host Disease 39Congenital Abnormalities 39Myeloproliferative Disorders 38Blast Crisis 38Lymphoma, Follicular 37Leukemia, Myelomonocytic, Chronic 37Multiple Myeloma 35Leukemia, Biphenotypic, Acute 35Lymphoma, Mantle-Cell 34Lymphoma, Large-Cell, Immunoblastic 31Lymphoma, B-Cell, Marginal Zone 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Recurrence 29Primary Myelofibrosis 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Anemia, Refractory, with Excess of Blasts 24Neoplasms, Plasma Cell 23Hematologic Neoplasms 23

Interventions

Epoetin Alfa 11Lenalidomide 5fludarabine phosphate 4Cyclosporine 4Cyclophosphamide 4fludarabine 3Filgrastim 3Darbepoetin alfa 3Busulfan 3Antilymphocyte Serum 3thymoglobulin 2Thiotepa 2Therapeutics 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Ferric Oxide, Saccharated 2Biopsy 2AP 1903 reagent 2venetoclax 1trametinib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1obinutuzumab 1neratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia × Methotrexate × Other hematologic neoplasm × Clear all
NCT00278265 2016-10-03

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

German CLL Study Group

Phase 2 Terminated
12 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Neutropenia, Leukemia, Large Granular Lymphocytic

NCT00301912 2012-10-02

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

University of California, San Francisco

Phase 2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Blast Crisis, Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡